Neurological Health: Early studies are exploring the use of GLP-1s for their potential neuroprotective effects, with research underway for conditions like Alzheimers and Parkinsons disease
It probably includes stopping eating after a certain time, adjusting certain medications, and arranging a ride home
Weve supported more than 30,000+ patients in reaching their wellness goals safely and effectively through guided GLP-1 programs and long-term care
adults had already taken GLP-1 at some point and the global market is projected to triple in the next five years, driven by high and rising levels of type-2 diabetes and obesity, aging populations, urbanization and public health initiatives: (2018-2030E) Global pharmaceutical companies dominate todays production: With ~300 clinical trials around the world, research continues into applications to other metabolic disorders, cardiovascular and kidney disease and neurological conditions
It also significantly improves blood sugar levels, often more than semaglutide, especially in those with insulin resistance or higher baseline A1C